Presented by Jeannie Gorman, MS, CCN | June 3, 2026 at 12 PM Pacific

This webinar will explore how the GI360™ provides a comprehensive view of the microbiome and dysbiosis, with insights into GLP-1 signaling pathways. Learn practical applications for patients with GI, autoimmune, cardiovascular, neurological, or skin conditions, and discover how stool insights can guide better clinical outcomes.

Learning Objectives:

• Describe the GI360™ complimentary methodologies and applications
• Identify patients who benefit from stool testing
• Interpret markers of dysbiosis and GLP-1-modulating bacteria
• Apply targeted probiotics, soluble fiber, diet, and dysbiosis therapies to support microbiome health and GLP-1 signal pathways
• Explain the role of retesting for optimizing microbiome and GLP-1-related outcomes

Presented by Dan Kalish, DC | July 7, 2026 at 12 PM Pacific

Estrogen balance is shaped by more than hormone production. It also depends on gut microbiome health, liver detoxification, and the body's ability to properly eliminate or recycle estrogen.

This class explains how the estrobolome influences estrogen metabolism, how Phase II liver detoxification prepares estrogen for excretion, and how gut dysbiosis and beta-glucuronidase activity can lead to excess estrogen recycling and hormone-related symptoms.

Learning Objectives:

• Understand the role of the estrobolome in estrogen regulation.
• Map the connection between liver detoxification, gut excretion, and estrogen recycling.
• Learn how beta-glucuronidase can reactivate estrogen for reabsorption.
• Recognize how gut dysbiosis may contribute to estrogen dominance.
• Identify key stool and hormone biomarkers related to estrogen clearance